Dr. Reddy's Laboratories Limited
RDY
$14.49
$0.140.98%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.48% | -0.65% | -10.02% | 10.05% | 11.65% |
| Total Depreciation and Amortization | 1.15% | 3.90% | 5.83% | -5.83% | 17.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 230.44% | -132.69% | 326.24% | 134.74% | -547.98% |
| Change in Net Operating Assets | -211.57% | 69.41% | -1,518.66% | 105.91% | -22.91% |
| Cash from Operations | -31.35% | 4.35% | -32.73% | 224.25% | -29.53% |
| Capital Expenditure | -25.79% | 25.38% | 9.43% | -3.91% | 5.31% |
| Sale of Property, Plant, and Equipment | -91.09% | 236.99% | 423.72% | -108.79% | -47.83% |
| Cash Acquisitions | -- | -- | -- | -- | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 20.40% | 64.88% | -214.74% | -338.30% | -95.94% |
| Cash from Investing | -5.70% | 51.26% | -45.96% | -137.80% | 71.62% |
| Total Debt Issued | 244.38% | 3,621.43% | 101.43% | -367.82% | -89.25% |
| Total Debt Repaid | -20.50% | 26.69% | -28.85% | 17.32% | 29.66% |
| Issuance of Common Stock | -67.39% | -53.06% | 1,681.82% | -56.00% | -81.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | -- | -- | -- | 100.00% |
| Other Financing Activities | 16.58% | 1.84% | -35.11% | 11.51% | -115.62% |
| Cash from Financing | 243.18% | -333.72% | 83.49% | -1,319.01% | -96.38% |
| Foreign Exchange rate Adjustments | 79.92% | 7.99% | -23.82% | 4,686.15% | 78.44% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 850.80% | 115.82% | -462.15% | -12.80% | -72.81% |